Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
The billionaire bill gates' foundation recently remade its public equity lineup, selling its Microsoft stake and conc...
Fox said it will acquire Roku in a $22 billion cash-and-stock deal, at $160 per Roku share. The transaction is slated...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
CoStar Group blends a high performing CRE data backbone with a slower moving homes marketplace. This piece breaks dow...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...
A 52-year-old with a $1.5 million 401(k) may deploy a five-year Roth conversion ladder to pull $40,000 annually, pena...
Traders worldwide can compete in a two-week sprint using Leveraged's Sprint accounts. The top performers will face of...
A fresh memory company touts a coiled-spring architecture to outpace NAND rivals amid AI-driven demand, sparking a co...
A wave of fresh analyst calls is shaping trading as Friday’s Wall Street topics include Amgen, Etsy, Eldorado Gold, G...
Wall Street is rotating away from AI momentum toward steady, long-running dividend payers. The beaten-down dividend a...
Zscaler is set to report Q3 after the close on May 28, 2026, with analysts eyeing ARR growth, AI monetization progres...